Clinical Applications of Simultaneous PET/MR Imaging Using (R)-[11C]-Verapamil with Cyclosporin A: Preliminary Results on a Surrogate Marker of Drug-Resistant Epilepsy. (Q38420352)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Clinical Applications of Simultaneous PET/MR Imaging Using (R)-[11C]-Verapamil with Cyclosporin A: Preliminary Results on a Surrogate Marker of Drug-Resistant Epilepsy.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26585254%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Clinical Applications of Simultaneous PET/MR Imaging Using (R)-[11C]-Verapamil with Cyclosporin A: Preliminary Results on a Surrogate Marker of Drug-Resistant Epilepsy (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26585254%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26585254%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26585254%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26585254%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26585254%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26585254%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26585254%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26585254%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26585254%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26585254%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26585254%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26585254%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

J-W Shin

1

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

K Chu

2

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

S A Shin

3

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

K-H Jung

4

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

S-T Lee

5

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Y-S Lee

6

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

J Moon

7

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

D Y Lee

8

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

J S Lee

9

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

D S Lee

10

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

S K Lee

11

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

publication date

19 November 2015

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26585254%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

American Journal of Neuroradiology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26585254%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

37

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26585254%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26585254%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

600-606

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26585254%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4566

21 January 2018

New avenues for anti-epileptic drug discovery and development

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4566

21 January 2018

Drug resistance in brain diseases and the role of drug efflux transporters.

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4566

21 January 2018

Role of CNS efflux drug transporters in antiepileptic drug delivery: overcoming CNS efflux drug transport

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4566

21 January 2018

Neuropathology of the blood-brain barrier and pharmaco-resistance in human epilepsy

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4566

21 January 2018

Imaging of cyclosporine inhibition of P-glycoprotein activity using 11C-verapamil in the brain: studies of healthy humans

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4566

21 January 2018

A pilot study to assess the efficacy of tariquidar to inhibit P-glycoprotein at the human blood-brain barrier with (R)-11C-verapamil and PET

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4566

21 January 2018

Assessment of regional differences in tariquidar-induced P-glycoprotein modulation at the human blood-brain barrier.

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4566

21 January 2018

Differential effects of global and cerebellar normalization on detection and differentiation of dementia in FDG-PET studies

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4566

21 January 2018

Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4566

21 January 2018

Quantification of F-18 FDG PET images in temporal lobe epilepsy patients using probabilistic brain atlas

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4566

21 January 2018

Pharmacoresistance in epilepsy: a pilot PET study with the P-glycoprotein substrate R-[(11)C]verapamil

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4566

21 January 2018

P-glycoprotein expression and function in patients with temporal lobe epilepsy: a case-control study

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4566

21 January 2018

Why clinical modulation of efflux transport at the human blood-brain barrier is unlikely: the ITC evidence-based position.

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4566

21 January 2018

Advances in PET imaging of P-glycoprotein function at the blood-brain barrier

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4566

21 January 2018

Duration and degree of cyclosporin induced P-glycoprotein inhibition in the rat blood-brain barrier can be studied with PET.

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4566

21 January 2018

Pharmacokinetics of P-glycoprotein inhibition in the rat blood-brain barrier

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4566

21 January 2018

Activity of P-Glycoprotein, a β-Amyloid Transporter at the Blood-Brain Barrier, Is Compromised in Patients with Mild Alzheimer Disease.

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4566

21 January 2018

Adjunctive use of verapamil in patients with refractory temporal lobe epilepsy: a pilot study

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A4566

21 January 2018

Identifiers

10.3174/AJNR.A4566

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26585254%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26585254%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38420352&oldid=1578275036"